Relcare Pharmaceuticals Private Limited

Relcare Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24290TG2020PTC139209 Incorporated 13 February 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2024
₹82 Lakh
▲ 286% YoY
Net profit · FY 2024
₹2.54 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹3.02 Lakh
EBITDA margin 3.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Relcare Pharmaceuticals Private Limited

Data last updated:

Relcare Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 February 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC139209. Its GSTIN is 36AAKCR0862J1Z3 (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lakshman Kapoor and Vijaylakshmi Kapoor.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 1 – 328 Kathiani Garden Shaikpet, Hyderabad, Telangana, India – 500008.

As per the financials filed for FY 2024, the company reported a revenue of ₹82 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.54 Lakh (net margin 3.1%) and EBITDA of ₹3.02 Lakh (EBITDA margin 3.7%).

Relcare Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0020469).

Company details

CIN U24290TG2020PTC139209
Registration Number 139209
Incorporation Date 13 February 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0020469

Recognitions & Rankings of Relcare Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0020469

Contact details

Relcare Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    8 – 1 – 328 Kathiani Garden Shaikpet, Hyderabad, Telangana, India – 500008
  • Industry
    Chemicals, Manufacturing, Other Chemical Product

To see the full contact details of Relcare Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Relcare Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Relcare Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Relcare Pharmaceuticals Private Limited, buy the company report.

Financials of Relcare Pharmaceuticals Private Limited

FY 2025 filings available

Relcare Pharmaceuticals Private Limited reported revenue of ₹82 Lakh (up 286% YoY) for FY 2024.

Revenue · FY 2024
₹82 Lakh ▲ 286%
Net profit · FY 2024
₹2.54 Lakh margin 3.1%
EBITDA · FY 2024
₹3.02 Lakh margin 3.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 286%
EBITDA CAGR growth
1 year
▲ 247%
3 years · compounded
▲ 76%

Revenue rose 286% in the latest year. EBITDA rose 247% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.02 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.54 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.7%
Net Profit Margin3.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Relcare Pharmaceuticals Private Limited, buy the company report.

Board of directors of Relcare Pharmaceuticals Private Limited

Relcare Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lakshman KapoorAdditional Director19 Jan 20224 Years 9 MonthsCurrent
Vijaylakshmi KapoorAdditional Director19 Jan 20224 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Relcare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Relcare Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAKCR0862J1Z3TelanganaActive28 Feb 2020

To see the full GST registrations and return filing status of Relcare Pharmaceuticals Private Limited, buy the company report.

Recent activity

Relcare Pharmaceuticals Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Pooja Kapoor ceased to be Director on 05 Feb 2022.

AGM
Relcare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Relcare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Pooja Kapoor ceased to be Director.
Ceased
Reena Gupta ceased to be Director.
Appointed
Lakshman Kapoor was appointed as Additional Director.
Appointed
Vijaylakshmi Kapoor was appointed as Additional Director.
Ceased
Gagan Bihari Jain ceased to be Director.
Incorporation
13 Feb 2020
Relcare Pharmaceuticals Private Limited was registered on 13 Feb 2020 with Roc Hyderabad & aged 6 years 8 months as per MCA records.

Frequently asked questions

Relcare Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 February 2020 (6+ years old) and is registered under CIN U24290TG2020PTC139209.

Relcare Pharmaceuticals has 2 current directors:

The latest financial statements of Relcare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Relcare Pharmaceuticals is 36AAKCR0862J1Z3, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Relcare Pharmaceuticals is U24290TG2020PTC139209. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Relcare Pharmaceuticals was incorporated on 13 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

Pooja Kapoor ceased to be Director on 05 Feb 2022. Reena Gupta ceased to be Director on 05 Feb 2022. Lakshman Kapoor was appointed as Additional Director on 19 Jan 2022. Relcare Pharmaceuticals has 5 board changes on record in total.

Yes, Relcare Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0020469).

The registered office of Relcare Pharmaceuticals is at 8 – 1 – 328 Kathiani Garden Shaikpet, Hyderabad, Telangana, India – 500008.

Relcare Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.